Lineará
Secretagogue & RegulatoryOpen access · public

B7-33

B7-33 is a 27-residue single-chain analogue of the B-chain of human gene-2 relaxin (H2 relaxin, RLN2), engineered as a functionally selective relaxin-family peptide receptor (RXFP1) agonist, with a C-terminal primary amide and the sequence VIKLSGRELVRAQIAISGMSTWSKRSL.

CAS 1818415-56-3Mol. weight 2986.58 g/molResearch Use Only · reference
2D structure of B7-33 (computed from the verified SMILES)
2D depiction computed with RDKit from the verified SMILES.
Computed 3D conformation (illustrative) · from the verified structure.

Identity & structure

V
I
K
L
S
G
R
E
L
V
R
A
Q
I
A
I
S
G
M
S
T
W
S
K
R
S
L
–NH₂

Primary sequence · 27 residues · C-terminal amide · 27-residue single-chain analogue of the H2-relaxin B-chain (positions 7-33). The native cysteines at positions 11 and 23 are substituted with serine so no disulfide forms; one Met contributes the lone sulfur; C-terminal primary amide. A single linear chain, unlike two-chain disulfide-bonded native relaxin and serelaxin..

B7-33 — identity and specification
Identity
CAS1818415-56-3
PubChem CID162662592
Also known asB7 33, B7-33 peptide, (B7-33)H2, H2 relaxin B-chain analogue, Single-chain relaxin analogue
Research classSecretagogue & Regulatory
Structure
Molecular formulaC131H229N41O36S
InChIKeyUAGASAJLEJWQIF-GARFIVTISA-N
SequenceVIKLSGRELVRAQIAISGMSTWSKRSL
Length27 residues
Analytical
Average molecular weight2986.58 g/mol
Monoisotopic mass2984.7070 Da (computed)

B7-33 is a 27-residue single-chain peptide derived from the B-chain of human gene-2 relaxin (H2 relaxin, RLN2): the first six residues of the relaxin B1–33 isoform are removed (leaving B-chain positions 7–33), the two native cysteines at positions 11 and 23 are substituted with serine so that no disulfide can form, and the C-terminus is capped as a primary amide. Its single-letter sequence VIKLSGRELVRAQIAISGMSTWSKRSL carries one methionine — the lone sulfur in the molecular formula C131H229N41O36S — and no cysteine. This single linear chain distinguishes B7-33 from native relaxin and serelaxin, which are two-chain, three-disulfide, insulin-like heterodimers. Identity is reconciled against PubChem CID 162662592: molecular formula and the stereo-defined InChIKey UAGASAJLEJWQIF-GARFIVTISA-N both match a peptide built independently from the sequence (twenty-nine stereocentres, none unassigned), and the average mass computed from the sequence (about 2986.6 Da) agrees with the value reported for this species. The name denotes B-chain residues 7 through 33 — 27 residues; a “26-residue” figure that circulates elsewhere is a miscount.

Reference context

B7-33 is a 27-residue single-chain analogue of the B-chain of human gene-2 relaxin (H2 relaxin, RLN2), engineered as a functionally selective relaxin-family peptide receptor (RXFP1) agonist, with a C-terminal primary amide and the sequence VIKLSGRELVRAQIAISGMSTWSKRSL. It is listed here strictly as an analytical reference entity — it is not sold, stocked, or certified by Lineará, and has no price or certificate of analysis. The data on this page is characterization only: molecular formula C131H229N41O36S and the values computed from it. "relaxin-family peptide receptor (RXFP1) agonist" is a structural-family descriptor; no biological activity, mechanism, or use is described or implied.

Listed solely as a characterized analytical reference — no representation is made as to any biological effect. For Research Use Only — not for human or veterinary use.

How B7-33 is characterized

Identity rests on the molecular formula and mass. Electrospray mass spectrometry (ESI-MS) measures the mass-to-charge ratio of the intact molecule; the average and monoisotopic masses are computed from the verified formula and cross-check the composition. The residue sequence and the modifications noted above define the structure.

CompositionMolecular formula · 27-residue peptide
MassAverage & monoisotopic · ESI-MS
IdentityCAS · PubChem CID · InChIKey

Frequently asked questions

What is B7-33?
B7-33 is a 27-residue single-chain analogue of the B-chain of human gene-2 relaxin (H2 relaxin, RLN2), engineered as a functionally selective relaxin-family peptide receptor (RXFP1) agonist, with a C-terminal primary amide and the sequence VIKLSGRELVRAQIAISGMSTWSKRSL. It is listed here strictly as an analytical reference entity — it is not sold, stocked, or certified by Lineará, and has no price or certificate of analysis. The data on this page is characterization only: molecular formula C131H229N41O36S and the values computed from it. "relaxin-family peptide receptor (RXFP1) agonist" is a structural-family descriptor; no biological activity, mechanism, or use is described or implied.
What is the amino-acid sequence of B7-33?
B7-33 has the sequence VIKLSGRELVRAQIAISGMSTWSKRSL. B7-33 is a 27-residue single-chain peptide derived from the B-chain of human gene-2 relaxin (H2 relaxin, RLN2): the first six residues of the relaxin B1–33 isoform are removed (leaving B-chain positions 7–33), the two native cysteines at positions 11 and 23 are substituted with serine so that no disulfide can form, and the C-terminus is capped as a primary amide. Its single-letter sequence VIKLSGRELVRAQIAISGMSTWSKRSL carries one methionine — the lone sulfur in the molecular formula C131H229N41O36S — and no cysteine. This single linear chain distinguishes B7-33 from native relaxin and serelaxin, which are two-chain, three-disulfide, insulin-like heterodimers. Identity is reconciled against PubChem CID 162662592: molecular formula and the stereo-defined InChIKey UAGASAJLEJWQIF-GARFIVTISA-N both match a peptide built independently from the sequence (twenty-nine stereocentres, none unassigned), and the average mass computed from the sequence (about 2986.6 Da) agrees with the value reported for this species. The name denotes B-chain residues 7 through 33 — 27 residues; a “26-residue” figure that circulates elsewhere is a miscount.
What is the molecular formula of B7-33?
B7-33 has the molecular formula C131H229N41O36S, giving an average molecular weight of 2986.58 g/mol and a computed monoisotopic mass of 2984.7070 Da.
What are the key chemical identifiers for B7-33?
The CAS Registry Number for B7-33 is 1818415-56-3. Its PubChem CID is 162662592 and its InChIKey is UAGASAJLEJWQIF-GARFIVTISA-N.
Is B7-33 a peptide?
Yes. B7-33 is a peptide — a chain of amino-acid residues joined by peptide bonds, 27 residues in length. Its identity is defined by that sequence and its molecular mass.
How is B7-33 stored and reconstituted?
As a research material, B7-33 is typically handled as a lyophilized (freeze-dried) powder. It is kept desiccated and cold — commonly 2–8 °C for short periods and −20 °C for longer storage — and reconstituted in sterile or bacteriostatic water. This is storage and handling information only, not a use protocol.
Does Lineará sell B7-33?
No. B7-33 is listed here only as an analytical reference entity. It is not part of the Lineará formulary, has no price or certificate of analysis, and is not offered for sale.
Is B7-33 approved for human use?
No. B7-33 is presented strictly as characterization reference data. It is not a drug, is not approved for any human or veterinary use, and must not be administered to humans or animals.

Data, tools & related references

References

  1. PubChem — compound identity, structure & computed properties (CID 162662592). PubChem →
  2. CAS Registry Number 1818415-56-3.

Research professionals only

Reference data

This monograph is characterization reference data. Lineará does not sell, stock, or certify B7-33.

áFor Research Use Only · Not for human or veterinary use · Not for diagnostic or therapeutic use